Anne Chiang, MD

Anne Chiang, MD, PhD, discusses treatment options for patients with extensive-stage small cell lung cancer.

Anne Chiang, MD, PhD, discusses the management of ​immune-related adverse effects in lung cancer. 

A new FDA program is giving patients and providers first-time access to patient-reported outcome data from cancer clinical trials of marketed treatments.

Consolidation of community oncology practices with hospital-based cancer centers is an accelerating trend that will affect future healthcare delivery models. This year, the Community Oncology Alliance reported hospital acquisitions and corporate mergers among 55% of 1338 community oncology practices surveyed, representing a 20% increase over the previous year's results.